Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chuan Sun

Showing results (391-400 of 469) with videos related to

Pageof 47
Sort By:
Journal of Cancer Research and Clinical Oncology|March 10, 2010
Long-term interferon-α treatment suppresses tumor growth but promotes metastasis capacity in hepatocellular carcinomaPeng-Yuan Zhuang, Ju-Bo Zhang, Wei Zhang, et al.
American Journal of Cancer Research|July 24, 2018
Invasive potential of hepatocellular carcinoma is enhanced by loss of selenium-binding protein 1 and subsequent upregulation of CXCR4Ping-Ting Gao, Guang-Yu Ding, Xuan Yang, et al.
Journal of Pharmaceutical Analysis|November 29, 2023
Monoclonal antibody targeting mu-opioid receptor attenuates morphine tolerance via enhancing morphine-induced receptor endocytosisJia-Jia Zhang, Chang-Geng Song, Miao Wang, et al.
American Journal of Cancer Research|June 1, 2017
Flot2 promotes tumor growth and metastasis through modulating cell cycle and inducing epithelial-mesenchymal transition of hepatocellular carcinomaCheng-Hao Wang, Xiao-Dong Zhu, De-Ning Ma, et al.
Journal of Cancer Research and Clinical Oncology|March 19, 2009
Intrahepatic cholangiocarcinoma: report of 272 patients compared with 5,829 patients with hepatocellular carcinomaXin-Da Zhou, Zhao-You Tang, Jia Fan, et al.
American Journal of Translational Research|January 22, 2019
Reduced selenium-binding protein 1 correlates with a poor prognosis in intrahepatic cholangiocarcinoma and promotes the cell epithelial-mesenchymal transitionXin-Yu Zhang, Ping-Ting Gao, Xuan Yang, et al.
Communications Biology|July 2, 2026
Electric fields trigger ceramide-dependent vesicle budding and boost the generation of small extracellular vesiclesShiwen Huang, Liangjing Chen, Chuan Sun, et al.
The Oncologist|June 17, 2010
High expression of macrophage colony-stimulating factor-1 receptor in peritumoral liver tissue is associated with poor outcome in hepatocellular carcinoma after curative resectionJin-Bin Jia, Wen-Quan Wang, Hui-Chuan Sun, et al.
Nature Plants|March 21, 2017
Rational design of high-yield and superior-quality riceDali Zeng, Zhixi Tian, Yuchun Rao, et al.
Annals of Surgical Oncology|September 30, 2022
Hepatectomy After Conversion Therapy Using Tyrosine Kinase Inhibitors Plus Anti-PD-1 Antibody Therapy for Patients with Unresectable Hepatocellular CarcinomaXiao-Dong Zhu, Cheng Huang, Ying-Hao Shen, et al.
Pageof 47

Showing results (391-400 of 469) with videos related to

Sort By:
Pageof 47
Journal of Cancer Research and Clinical Oncology|March 10, 2010
Long-term interferon-α treatment suppresses tumor growth but promotes metastasis capacity in hepatocellular carcinomaPeng-Yuan Zhuang, Ju-Bo Zhang, Wei Zhang, et al.
American Journal of Cancer Research|July 24, 2018
Invasive potential of hepatocellular carcinoma is enhanced by loss of selenium-binding protein 1 and subsequent upregulation of CXCR4Ping-Ting Gao, Guang-Yu Ding, Xuan Yang, et al.
Journal of Pharmaceutical Analysis|November 29, 2023
Monoclonal antibody targeting mu-opioid receptor attenuates morphine tolerance via enhancing morphine-induced receptor endocytosisJia-Jia Zhang, Chang-Geng Song, Miao Wang, et al.
American Journal of Cancer Research|June 1, 2017
Flot2 promotes tumor growth and metastasis through modulating cell cycle and inducing epithelial-mesenchymal transition of hepatocellular carcinomaCheng-Hao Wang, Xiao-Dong Zhu, De-Ning Ma, et al.
Journal of Cancer Research and Clinical Oncology|March 19, 2009
Intrahepatic cholangiocarcinoma: report of 272 patients compared with 5,829 patients with hepatocellular carcinomaXin-Da Zhou, Zhao-You Tang, Jia Fan, et al.
American Journal of Translational Research|January 22, 2019
Reduced selenium-binding protein 1 correlates with a poor prognosis in intrahepatic cholangiocarcinoma and promotes the cell epithelial-mesenchymal transitionXin-Yu Zhang, Ping-Ting Gao, Xuan Yang, et al.
Communications Biology|July 2, 2026
Electric fields trigger ceramide-dependent vesicle budding and boost the generation of small extracellular vesiclesShiwen Huang, Liangjing Chen, Chuan Sun, et al.
The Oncologist|June 17, 2010
High expression of macrophage colony-stimulating factor-1 receptor in peritumoral liver tissue is associated with poor outcome in hepatocellular carcinoma after curative resectionJin-Bin Jia, Wen-Quan Wang, Hui-Chuan Sun, et al.
Nature Plants|March 21, 2017
Rational design of high-yield and superior-quality riceDali Zeng, Zhixi Tian, Yuchun Rao, et al.
Annals of Surgical Oncology|September 30, 2022
Hepatectomy After Conversion Therapy Using Tyrosine Kinase Inhibitors Plus Anti-PD-1 Antibody Therapy for Patients with Unresectable Hepatocellular CarcinomaXiao-Dong Zhu, Cheng Huang, Ying-Hao Shen, et al.
Pageof 47